Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Avidity Biosciences (RNA) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Avidity Biosciences (RNA) over the last 6 years, with Q3 2025 value amounting to 0.01.

  • Avidity Biosciences' Asset Utilization Ratio rose 7594.68% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year increase of 7594.68%. This contributed to the annual value of 0.01 for FY2024, which is 3411.03% down from last year.
  • Latest data reveals that Avidity Biosciences reported Asset Utilization Ratio of 0.01 as of Q3 2025, which was up 7594.68% from 0.01 recorded in Q2 2025.
  • Avidity Biosciences' Asset Utilization Ratio's 5-year high stood at 0.03 during Q2 2021, with a 5-year trough of 0.01 in Q1 2025.
  • For the 5-year period, Avidity Biosciences' Asset Utilization Ratio averaged around 0.02, with its median value being 0.02 (2023).
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 6045.35% in 2024, then skyrocketed by 7594.68% in 2025.
  • Over the past 5 years, Avidity Biosciences' Asset Utilization Ratio (Quarter) stood at 0.02 in 2021, then fell by 21.06% to 0.02 in 2022, then decreased by 7.77% to 0.02 in 2023, then tumbled by 57.26% to 0.01 in 2024, then soared by 75.19% to 0.01 in 2025.
  • Its Asset Utilization Ratio stands at 0.01 for Q3 2025, versus 0.01 for Q2 2025 and 0.01 for Q1 2025.